Literature DB >> 29527030

Aceclofenac-Induced Erythema Annulare Centrifugum.

Dilip Meena1, Payal Chauhan1, Neirita Hazarika1, Naveen Kumar Kansal1, Arvind Gupta2.   

Abstract

Erythema annulare centrifugum (EAC) is characterised by slowly enlarging annular erythematous lesions and is thought to represent a clinical reaction pattern to infections, medications, and rarely, underlying malignancy. Causative drugs include chloroquine, cimetidine, gold sodium thiomalate, amitriptyline, finasteride, etizolam etc. We present a case of 40-year-old woman who presented to us with a 10 days history of nonpruritic, peripherally growing annular erythematous eruption. She had a history of recent onset of joint pain, for which she was taking aceclofenac 90 mg once a day for 5 days prior to the onset of the rash. This was confirmed on biopsy as EAC. The rash promptly subsided after stopping the drug. We report this case as there was no previous report of aceclofenac induced EAC.

Entities:  

Keywords:  Aceclofenac; drug induced; erythema annulare centrifugum

Year:  2018        PMID: 29527030      PMCID: PMC5838759          DOI: 10.4103/ijd.IJD_728_16

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


  6 in total

1.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

2.  Erythema annulare centrifugum due to hydroxychloroquine sulfate and chloroquine sulfate.

Authors:  P J Ashurst
Journal:  Arch Dermatol       Date:  1967-01

3.  Etizolam-induced superficial erythema annulare centrifugum.

Authors:  K Kuroda; H Yabunami; Y Hisanaga
Journal:  Clin Exp Dermatol       Date:  2002-01       Impact factor: 3.470

4.  Erythema annulare centrifugum.

Authors:  G S Bressler; R E Jones
Journal:  J Am Acad Dermatol       Date:  1981-05       Impact factor: 11.527

5.  Erythema annulare centrifugum secondary to treatment with finasteride.

Authors:  Anwar Al Hammadi; Yuka Asai; Minda L Patt; Denis Sasseville
Journal:  J Drugs Dermatol       Date:  2007-04       Impact factor: 2.114

6.  New concepts on erythema annulare centrifugum: a clinical reaction pattern that does not represent a specific clinicopathological entity.

Authors:  M Ziemer; K Eisendle; B Zelger
Journal:  Br J Dermatol       Date:  2008-08-20       Impact factor: 9.302

  6 in total
  1 in total

1.  Recurrent Erythema Annulare Centrifugum due to Influenza Type A.

Authors:  Luca Ena; Vittorio Mazzarello; Marco Ferrari; Pasquale Ena
Journal:  Case Rep Dermatol       Date:  2021-02-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.